|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/30 | (2006.01) | ||
| C07K 16/40 | (2006.01) | ||
| C07K 16/46 | (2006.01) |
| (11) | Number of the document | 2748201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12750364.7 |
| Date of filing the European patent application | 2012-08-21 | |
| (97) | Date of publication of the European application | 2014-07-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-13 |
| (46) | Date of publication of the claims translation | 2018-02-26 |
| (86) | Number | PCT/EP2012/066215 |
| Date | 2012-08-21 |
| (87) | Number | WO 2013/026833 |
| Date | 2013-02-28 |
| (30) | Number | Date | Country code |
| 11178370 | 2011-08-23 | EP | |
| 12168192 | 2012-05-16 | EP |
| (72) |
AST, Oliver, CH
BRUENKER, Peter, CH
FAUTI, Tanja, CH
FREIMOSER-GRUNDSCHOBER, Anne, CH
NEUMANN, Christiane, CH
KLEIN, Christian, CH
MOESSNER, Ekkehard, CH
UMANA, Pablo, CH
|
| (73) |
Roche Glycart AG,
Wagistrasse 18, 8952 Schlieren,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Dvigubai specifinė T ląsteles aktyvinantį antigeną surišanti molekulė |
| BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 14 | 289.00 EUR |
| 2026-08-21 |